Rosie Scuccimarri

Learn More
BACKGROUND Hemolytic anemia is a rare but reported side effect of intravenous immunoglobulin (IVIG) therapy. The risk of significant hemolysis appears greater in those patients who receive high dose IVIG. The etiology is multifactorial but may relate to the quantity of blood group antibodies administered via the IVIG product. FINDINGS We describe 4(More)
OBJECTIVE To describe probabilities and characteristics of disease flares in children with juvenile idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk of flare. METHODS We studied children in the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) prospective inception cohort. A flare(More)
BACKGROUND Pediatric rheumatic diseases are chronic illnesses that can cause considerable disease burden to children and their families. There is limited epidemiologic data on these diseases in East Africa. The aim of this study was to assess the spectrum of pediatric rheumatic diagnoses in an in-patient setting and determine the accuracy of ICD-10 codes in(More)
The incidence of Kawasaki disease in Maghreb countries is apparently low, unlike those living in the province of Quebec, Canada. This retrospective study compared Maghrebi children living in Quebec to the countries of origin, Morocco, Algeria, and Tunisia. The annualized incidence rate in Quebec (18.49/year/100 000 children under 5 years of age) was 4 to 12(More)
Purpose To examine the remission rates and functional outcomes in an inception cohort of patients with juvenile idiopathic arthritis (JIA). Methods The Research in Arthritis in Canadian Children, emphasizing Outcomes (ReACCh-Out) cohort is a 16-centre inception cohort of patients with JIA enrolled within 1 year of diagnosis. All patients who completed 5(More)
Purpose Compromised bone health is recognized as an important source of morbidity among children with glucocorticoid (GC)-treated rheumatic diseases (RD). The aims of this study were to determine the frequency and characteristics of incident vertebral fractures (VF) 12 months after GC initiation in a prospectively-followed cohort of children with RD, and to(More)
Purpose Corticosteroids (CS) are commonly used for the treatment of children with rheumatic diseases (RD) at presentation or relapse; the dose is reduced or discontinued with disease improvement. The aim of this study was to examine the dose-related effect of CS on the timing of peak body mass index (BMI) in children with RD and the degree of restitution to(More)
  • 1